Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN) (LIFE-SCREEN)

The investigators propose a randomized controlled trial to develop and evaluate the impact of promoting advice on diet and lifestyle recommendations for cancer prevention at colorectal cancer screening among individuals who may be at higher risk for colorectal cancer (CRC). The specific objectives of this study are to 1) develop a lifestyle intervention based on evidenced-based diet and lifestyle recommendations (i.e. those proposed by the World Cancer Research Fund (WCRF) and the French National Cancer Institute); 2) evaluate the effect of the intervention on the adherence to the target diet and lifestyle recommendations as well as other subjective health measures, including quality of life; 3) evaluate the effect of the intervention on anthropometrics.

Study Overview

• Status: Recruiting
• Conditions: Colorectal Cancer; Colorectal Cancer Screening; Colorectal Cancer Prevention
• Intervention / Treatment: Behavioral: Diet and lifestyle advice following a positive FIT test and diagnostic colonoscopy

Detailed Description

A pilot study was launched on March 23rd 2022 to assess the feasibility and acceptance of the LIFE-SCREEN study protocol. During the pilot study, participants were asked to complete several questionnaires about their lifestyle and health, while also having their anthropometrics measured and optional their blood taken and faecal sample collected. Evaluation questionnaires were completed by all participants and some participated in focus group meetings. Based upon this pilot study, it was decided in 2024 to drop the biospecimen collections due to feasibility issues.

This RCT study launched in November 2024 will be a parallel, two-arm, randomized controlled trial (RCT) in individuals at higher risk of colorectal cancer (CRC), comparing an evidence-based diet and lifestyle advice intervention with 'usual care'. Participants will be recruited during CRC screening and will be included if they have a positive faecal immunochemical test (FIT) and are diagnosed with adenomas but are CRC negative during the colonoscopy. The advice provided will be developed based on the World Cancer Research Fund (WCRF) & French National Cancer Institute (INCA) evidence-based diet and lifestyle recommendations using the habit-theory and will be delivered using multiple materials (e.g. leaflets, posters and digital information) by health professionals in hospitals based in the Rhone region, France. Invitation to participate in the trial will be performed by the gastroenterologist during the clinical visit to provide information on colonoscopy, but the delivery of the intervention and baseline measurement will happen two to three weeks after the colonoscopy. Data will be collected at baseline, 3, 6 and 12 months. At baseline, participants will be required to answer questionnaires on sociodemographic and medical history. At all aforementioned time points, online or paper-based questionnaires will be administered to collect information on diet and lifestyle behaviours, knowledge on healthy lifestyle, quality of life and medical therapy. Participants will also have their anthropometric measured during baseline and follow-up appointments. The primary outcome of this intervention will be adherence to target recommendations at 3 months and beyond. Univariate and multivariate statistical analyses as well as qualitative analyses will be performed.

Providing lifestyle advice for cancer prevention at screening programs is a new field in public health that has the potential to be cost-effective, convenient, appealing and widereaching. It may also help to reach individuals at higher risk at a time-window when they adherence to cancer prevention recommendations, as well as on quality of life and body weight among individuals at higher risk of CRC.

• Study Type: Interventional
• Enrollment (Estimated): 800
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Inge Huybretchts, PhD; Phone Number: +33695925958; Email: huybrechtsi@iarc.who.int
• Study Contact Backup: Name: Genevieve Nicolas, MSc; Email: nicolasg@iarc.who.int

Study Locations

• France
  • France
    • Lyon, France, France, 69008
      • Recruiting
      • Centre Leon Berard
      • Contact: Aurélia Maire, MSc; Phone Number: +33469856362; Email: aurelia.maire@lyon.unicancer.fr
      • Contact: Olivia Pérol, PhD; Phone Number: +33478782897; Email: olivia.perol@lyon.unicancer.fr
      • Principal Investigator: Anne Cattey-Javouhey, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Having read the information note and agreeing to participate
• Will and availability to be committed for a full year
• At high risk for CRC but CRC negative
• Affiliated to a health security system
• Having a score on the adherence to the recommendation lower than or equal to 7 out of 9 at baseline.
• Able to read, write and understand French

Exclusion Criteria:

• Under a strict diet such as meal replacements, diets for co-morbidities such as diabetes
• Immobile due to physical constraints (e.g. handicap that is not compatible with physical activities)
• Extensive intestinal surgery such as colectomy or surgical resection of the colon
• Chronic gastrointestinal illness (IBD, IBS, celiac disease)
• Colorectal cancer confirmed or history of a primary cancer
• Severe malnutrition
• Pregnant
• Participation in another lifestyle study

NB : For this study, there is no exclusion period from other research, and participants can simultaneously take part in another study unless it concerns lifestyle.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Intervention; Colorectal cancer free participants receive evidence-based diet and lifestyle advice in addition to the 'usual care' following a positive FIT test and diagnostic colonoscopy	Behavioral: Diet and lifestyle advice following a positive FIT test and diagnostic colonoscopy; Participants will be recruited during CRC screening and will be included if they have a positive faecal immunochemical test (FIT) and are diagnosed with adenomas but are CRC negative during the colonoscopy. Participants receive evidence-based diet and lifestyle advice intervention with 'usual care'
No Intervention: Control; Colorectal cancer free participants receive the 'usual care' following a positive FIT test and diagnostic colonoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Adherence to the evidence-based lifestyle recommendations	The primary outcome of the trial will be adherence to the evidence-based lifestyle recommendations (expressed as an adherence score on the individual lifestyle recommendations). Score : unabbreviated scale title : World Cancer Research Fund's (WCRF); minimum value = 0 (more unhealthy behaviours) / maximum value = 7 (more healthy behaviours)	3 months

Collaborators and Investigators

• Sponsor: Centre Leon Berard
• Collaborators: University of Bordeaux; Hôpital Edouard Herriot; International Agency for Research on Cancer
• Investigators: Study Director: Inge Huybretchts, PhD, International Agency Research Cancer

Study record dates

Study Major Dates

• Study Start (Actual): January 26, 2026
• Primary Completion (Estimated): November 15, 2027
• Study Completion (Estimated): February 15, 2028

Study Registration Dates

• First Submitted: October 24, 2024
• First Submitted That Met QC Criteria: February 10, 2025
• First Posted (Actual): February 14, 2025

Study Record Updates

• Last Update Posted (Actual): May 5, 2026
• Last Update Submitted That Met QC Criteria: April 29, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Keywords: physical activity; colorectal cancer; nutrition; screening; primary prevention; recommendations
• Additional Relevant MeSH Terms: Neoplasms by Site; Neoplasms; Intestinal Diseases; Gastrointestinal Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Colonic Diseases; Behavior; Colorectal Neoplasms; Motor Activity; Diet, Food, and Nutrition; Physiological Phenomena; Nutritional Physiological Phenomena; Diet
• Other Study ID Numbers: LIFE-SCREEN (ET 24-226)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No